Lilly profit tops Street view, but shares fall
NEW YORK (Reuters) – Eli Lilly and Co posted third-quarter profit well above Wall Street expectations on Wednesday on strong performance of its major prescription drugs and lower taxes, but it said an inventory benefit that helped results might reverse in the fourth quarter.
October 21, 2009
NEW YORK (Reuters) - Eli Lilly and Co posted third-quarter profit well above Wall Street expectations on Wednesday on strong performance of its major prescription drugs and lower taxes, but it said an inventory benefit that helped results might reverse in the fourth quarter.
